We then evaluated the effect of IHMT-337 on glioma cell migration, revealing a significant inhibition of cell migration promoted by EZH2 overexpression (Fig. 5f), as well as the suppression of cell migration induced by KCC2 downregulation (Fig. 5g). This evidence concerns the gene EZH2 and central nervous system cancer.